The article discusses the potential for weight-loss medications like Wegovy and Mounjaro to create a new cycle of yo-yo dieting.While these drugs, which mimic hormones to reduce appetite and increase fullness, have been transformative for many with obesity, their long-term effectiveness is questionable.

Studies show that weight regain is common after discontinuation, leading to a repetitive pattern of losing weight, regaining it, and restarting treatment.This cycle is driven by factors like cost, side effects, and eligibility rules.Experts emphasize that medication should be seen as a tool to build sustainable habits, not a permanent solution.Obesity is a complex condition influenced by biology, environment, and behavior, requiring long-term support.

The article highlights the need for sustained behavior change and cautions against relying solely on medication, as it doesn't address underlying factors like diet, physical activity, and socioeconomic conditions.Regulatory warnings against using these drugs for cosmetic weight loss also underscore the importance of medical oversight.